European Survey: Risk of Cyanide Poisoning in Smoke Inhalation
NCT ID: NCT01386788
Last Updated: 2016-09-28
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
102 participants
OBSERVATIONAL
2009-04-30
2012-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
In fact, cyanide poisoning is considerably more common than is generally appreciated. Multiple clinical and post-mortal studies have demonstrated that HCN contributes to the toxicity of fire smoke.
Cyanide acts primarily through its strong affinity for the iron-containing heme moiety, binding to numerous critical enzyme systems in the body and rendering them inactive. Of late, increasing attention has been paid to the relationship of cyanide and nitric oxide. The interactions appear to be complex, with cyanide inducing nitric oxide production by binding to N-methyl-D-aspartate (NMDA) receptors, as well as binding to nitric oxide synthase. The latter may be overcome by the presence of nitric oxide synthase inhibitors.
Probably, the majority of the cyanide poisoning cases are due to smoke inhalation in closed-space fires.
So far, there are no clear data available on the prevalence of cyanide poisoning in smoke inhalation.
This information would be of great interest for all emergency physicians since a proven or supposed cyanide poisoning does not only requires an intensive supportive care, including the administration of supplemental oxygen and artificial ventilation, blood pressure support, and anticonvulsants, but also a rapid administration of a cyanide antidote.
Therefore, it is the goal of this survey to assess the prevalence of cyanide poisoning in smoke inhalation victims. Only the data of patients with a cyanide measurement before specific antidote treatment will be included
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Hookah Smoking, Carbon Monoxide, and Coronary Endothelial Function
NCT03166787
Effects of Carbon Monoxide Breathing on Blood Vessel Function
NCT03067701
Study of Chokeberry to Reduce Cardiovascular Disease Risk in Former Smokers
NCT01541826
Oxidative DNA Damage Enhancement by Vitamin C Among Narghile Smokers and Non-smokers
NCT07141823
Propylene Glycol/Glycerol Intake and Cardiorespiratory Function
NCT03410511
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
In fact, cyanide poisoning is considerably more common than is generally appreciated. Multiple clinical \[1-4\] and post-mortal studies \[5-10\] have demonstrated that HCN contributes to the toxicity of fire smoke.
Cyanide acts primarily through its strong affinity for the iron-containing heme moiety, binding to numerous critical enzyme systems in the body and rendering them inactive \[11\]. Of late, increasing attention has been paid to the relationship of cyanide and nitric oxide. The interactions appear to be complex, with cyanide inducing nitric oxide production by binding to N-methyl-D-aspartate (NMDA) receptors \[12\], as well as binding to nitric oxide synthase. The latter may be overcome by the presence of nitric oxide synthase inhibitors.
Probably, the majority of the cyanide poisoning cases are due to smoke inhalation in closed-space fires.
So far, there are no clear data available on the prevalence of cyanide poisoning in smoke inhalation.
This information would be of great interest for all emergency physicians since a proven or supposed cyanide poisoning does not only requires an intensive supportive care, including the administration of supplemental oxygen and artificial ventilation, blood pressure support, and anticonvulsants, but also a rapid administration of a cyanide antidote.
Therefore, it is the goal of this survey to assess the prevalence of cyanide poisoning in smoke inhalation victims. Only the data of patients with a cyanide measurement before specific antidote treatment will be included.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Smoke Inhalation patients
Closed space fire, Soot deposits, Altered mental status Blood specimen before intravenous antidote treatment (cyanide measurement) Known delay between end of smoke exposure and blood sampling
There is no intervention planned (observational)
No intervention foreseen
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
There is no intervention planned (observational)
No intervention foreseen
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Blood specimen before intravenous antidote treatment (cyanide measurement)
* Known delay between end of smoke exposure and blood sampling
* Malaise and/or Headache and/or Altered mental status in fire workers
Exclusion Criteria
* Multiple trauma, Blast
* Patient pronounced dead at scene without resuscitation attempt
* Patient in whom the time elapsed between the end of exposure and blood sampling is greater than 2 hours
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Dr. Ernst MW Koch
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dr. Ernst MW Koch
Dr
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Thomas Zilker, Prof.
Role: STUDY_CHAIR
TU München
Carlo A Locatelli, Prof
Role: STUDY_CHAIR
IRCCS Fondazione Maugeri
Frédéric Baud, Prof
Role: STUDY_CHAIR
Hôpital Lariboisière
Guillermo Burillo-Putze, Prof
Role: STUDY_CHAIR
Universidad de Teneriffe
Jean-Philippe Fauville, Dr
Role: STUDY_CHAIR
To be added
Francois Levy, Dr
Role: STUDY_CHAIR
To be added
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Prof. Dr. Götz Geldner
Ludwigsburg, , Germany
Prof. Th. Zilker
München, , Germany
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Geldner G, Koch EM, Gottwald-Hostalek U, Baud F, Burillo G, Fauville JP, Levi F, Locatelli C, Zilker T. Report on a study of fires with smoke gas development : determination of blood cyanide levels, clinical signs and laboratory values in victims. Anaesthesist. 2013 Aug;62(8):609-16. doi: 10.1007/s00101-013-2209-3. Epub 2013 Aug 7.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2009-010202-11
Identifier Type: OTHER
Identifier Source: secondary_id
EML015722-600
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.